Printer Friendly

ORTHOMET RECEIVES FDA APPROVAL TO MARKET NEW HIP PRODUCTS

 MINNEAPOLIS, Jan. 5 /PRNewswire/ -- Orthomet, Inc. (NASDAQ: OMET) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) under Section 510(k) of the Food, Drug and Cosmetic Act to market its new hip stems and cups that have a hydroxylapatite (HA) coating, and its new ceramic femoral heads.
 The new products will expand Orthomet offerings into segments of the orthopaedic reconstructive hip market that the company did not address previously.
 Orthomet, Inc. designs, manufactures and markets selected orthopaedic reconstructive implant products and related surgical instrumentation.
 -0- 1/5/93
 /CONTACT: James C. Hawley, executive vice president of Orthomet, 612-944-6112/
 (OMET)


CO: Orthomet, Inc. ST: Minnesota IN: MTC SU:

DS -- MN013 -- 1924 01/05/93 17:20 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 5, 1993
Words:124
Previous Article:JTB WORLD VACATIONS INC. JOINS EARTHWINDS HILTON AS CONTRIBUTING SPONSOR TO DARING BALLOON MISSION
Next Article:YUKON BOARD OF DIRECTORS SIGN LETTER OF INTENT TO MOVE MANUFACTURING OPERATIONS TO JAMESTOWN; KELLY TO ADVISE
Topics:


Related Articles
ORTHOMET, INC. RECEIVES FDA APPROVAL FOR EXTENSION TO KNEE PRODUCT LINE; BEGINS TRIAL DISTRIBUTION IN U.S. OF 3M SHOULDER PRODUCT
ORTHOMET ANNOUNCES APPOINTMENT OF CHAIRMAN AND CEO
ORTHOMET ANNOUNCES AGREEMENT TO ACQUIRE ENDOTEC
ORTHOMET NAMES NEW NATIONAL SALES MANAGER
ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT; ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING
ORTHOMET OBTAINS LICENSE FROM MAYO FOR FINGER JOINT REPLACEMENT PRODUCT
ORTHOMET RECEIVES FDA APPROVAL TO MARKET ION IMPLANTED FEMORAL HEADS FOR TOTAL HIP REPLACEMENT
ORTHOMET SALES UP 40 PERCENT FOR FISCAL YEAR
FDA GRANTS ORTHOMET APPROVAL TO MARKET IMPORTANT ADDITIONS TO ITS KNEE PRODUCT LINE
ORTHOMET AND KIRSCHNER SIGN LETTER OF INTENT TO MERGE

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters